...
首页> 外文期刊>HIV therapy >MHC-l-restricted HIV epitope processing, immune control and immunogen design
【24h】

MHC-l-restricted HIV epitope processing, immune control and immunogen design

机译:MHC-1限制的HIV表位加工,免疫控制和免疫原设计

获取原文
获取原文并翻译 | 示例
           

摘要

More than 25 years after the discovery of HIV and despite several vaccine trials, the correlates of immune protection are still not identified. Successful vaccine strategies will likely involve induction of both humoral and cellular immunity in order to prevent or limit HIV infection and to stimulate protective immune responses in HIV-infected individuals. The major difficulties in this quest include the various mechanisms of immune escape developed by HIV and the fact that not all immune responses against HIV have strong antiviral functions. This article will focus on an underestimated aspect of any T-cell-based arm of vaccine strategies: the mechanisms of epitope processing and its contribution to the pattern of HIV-specific CD8~+ T-cell responses. This article will also present current complementary research approaches towards the identification of CD8~+ T-cell protective immune responses and the design of immunogens aimed at selectively inducing CD8~+ T-cell protective immune responses against HIV, one of several critical requirements for an efficient vaccine design.
机译:发现艾滋病病毒已有25年以上,尽管进行了几次疫苗试验,但仍未确定免疫保护的相关性。成功的疫苗策略可能涉及诱导体液免疫和细胞免疫,以预防或限制HIV感染并刺激HIV感染者的保护性免疫应答。该任务的主要困难包括艾滋病毒发展出的各种免疫逃逸机制,以及并非所有针对艾滋病毒的免疫反应都具有强大的抗病毒功能这一事实。本文将重点介绍疫苗策略中任何以T细胞为基础的方法的被低估的方面:表位加工的机制及其对HIV特异性CD8〜+ T细胞反应模式的贡献。本文还将介绍目前用于鉴定CD8〜+ T细胞保护性免疫应答的补充研究方法,以及旨在选择性诱导针对HIV的CD8〜+ T细胞保护性免疫应答的免疫原设计,这是对HIV的几个关键要求之一。有效的疫苗设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号